Events

Join CKD Pharm as they award their 2026 Golden Ticket!

Chong Kun Dang Pharmaceutical Corp. (CKD Pharm), a leading South Korean pharmaceutical company, specializes in API manufacturing, cGMP-certified production, and new drug development. Strengthened by various U.S. partnerships, its R&D spans early discovery, clinical trials, and commercialization. Committed to “Better Life through Better Medicine,” CKD Pharm seeks to enhance Korea-U.S. pharmaceutical collaboration.

At this special pitch event, three finalist start ups will take the stage to present their groundbreaking research and pitch for the chance to win a Golden Ticket, helping one company further their research at LabCentral and the opportunity to accelerate their groundbreaking research.

Join us for an exciting evening as we hear from promising founders and announce the recipient of the 2026 CKD Pharm Golden Ticket!

Register here!